AVROBIO Inc. (AVRO) deprioritizing its Fabry disease program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026


Go back to AVROBIO Inc. (AVRO) deprioritizing its Fabry disease program

AVROBIO Reprioritizes Pipeline Programs

January 4, 2022 7:00 AM UTC

Fabry disease program to be deprioritized, shifting focus to other clinical-stage programs in lysosomal disorder pipeline

Data updates for cystinosis and Gaucher disease type 1 programs planned for 1H 2022, with regulatory interactions anticipated across multiple programs in 2022

Cash runway to be extended into first quarter of 2024

CAMBRIDGE, Mass.--(BUSINESS... More